#biotech

4 articles

Markets

Scientists Reverse 60 Years of Cellular Aging as Longevity Funding Reaches $12.1 Billion

Oct 26, 20262m read

Markets

Moderna Stock Drops 25% Despite Positive Phase 3 Cancer Vaccine Trial Data

Oct 23, 20263m read

Markets

Moderna Surges 663% in 2026 to Become Top S&P 500 Stock Ahead of Cancer Data

Oct 10, 20263m read

Markets

Morgan Stanley Identifies $70B Alzheimer's and $10B Gene-Editing Opportunities

Oct 1, 20262m read